(VIANEWS) – OKEA (OKEA.OL), CATANA GROUP (CATG.PA), ORKLA (ORK.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. OKEA (OKEA.OL)
66.5% sales growth and 32.98% return on equity
OKEA ASA, an oil and gas company, engages in the development and production of oil and gas in the Norwegian continental shelf. The company holds 44.56% interests in Draugen, 12% interests in Gjøa, 9.2385% interests in Ivar Aasen, 6% interests in Nova, and 15% interests in Yme assets. OKEA ASA was incorporated in 2015 and is headquartered in Trondheim, Norway.
Earnings Per Share
As for profitability, OKEA has a trailing twelve months EPS of kr6.27.
PE Ratio
OKEA has a trailing twelve months price to earnings ratio of 4.1. Meaning, the purchaser of the share is investing kr4.1 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 32.98%.
Volume
Today’s last reported volume for OKEA is 270648 which is 52.51% below its average volume of 570016.
Yearly Top and Bottom Value
OKEA’s stock is valued at kr25.70 at 16:20 EST, way under its 52-week high of kr41.36 and higher than its 52-week low of kr24.50.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Dec 1, 2023, the estimated forward annual dividend rate is 4 and the estimated forward annual dividend yield is 14.74%.
More news about OKEA.
2. CATANA GROUP (CATG.PA)
39.4% sales growth and 30.39% return on equity
SA Catana Group manufactures and sells pleasure boats, sails, and motors in France and internationally. It also offers boat work, garage rentals, guarding, and berth services. The company markets its products under the CATANA, BALI, and CATSPACE brands. SA Catana Group was founded in 2001 and is headquartered in Canet-en-Roussillon, France.
Earnings Per Share
As for profitability, CATANA GROUP has a trailing twelve months EPS of €0.57.
PE Ratio
CATANA GROUP has a trailing twelve months price to earnings ratio of 8.69. Meaning, the purchaser of the share is investing €8.69 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 30.39%.
Sales Growth
CATANA GROUP’s sales growth is 39.4% for the present quarter and 39.4% for the next.
More news about CATANA GROUP.
3. ORKLA (ORK.OL)
17.8% sales growth and 12.71% return on equity
Orkla ASA engages in branded consumer goods, and industrial and financial investment businesses. The company offers branded products, including frozen pizza, ketchup, soups, sauces, bread toppings, and ready-to-eat meals through grocery channels, as well as food service, convenience stores, and petrol stations. It also provides confectionery, biscuit, and snack products; and develops bran and crispbread products, as well as energy snack meals. In addition, the company offers personal care and cleaning products; dietary supplement, sport nutrition, and weight control products; wound care products and first aid equipment; painting tools; basic and wool garments for men, women, and children; and professional cleaning products. Further, it operates Gymgrossisten, Proteinfabrikken, Bodystore, and Fitnessmarket e-commerce portals for health and sports nutrition products; and restaurants. Additionally, the company supplies margarine and butter blends, bread and cake improvers and mixes, yeast, marzipan, and ice cream ingredients; produces and supplies hydro power to the Nordic power market; and develops and sells real estate properties. It offers its food products under the Grandiosa, TORO, Stabburet, Felix, Paulúns, NATURLI', Abba, Beauvais, Den Gamle Fabrik, Spilva, and Vitana brands; confectionery and snacks under the KiMs, Nidar, Stratos, Sætre, Göteborgs Kex, OLW, Panda, Laima, Selga, Taffel, Kalev, and Nói Síríus brands; health and sports nutrition under e Zalo, Jif, Bliw, Grumme, Blenda, Define, Möller's, Collett, Nutrilett, Maxim, Norgesplaster, and Salvequick brands; and food ingredients under the Odense, Mors Hjemmebakte, KronJäst, Bakkedal, and NATURLI brands. It has operations in Norway, Sweden, Denmark, Finland, Iceland, the Baltics, rest of Europe, and internationally. The company was founded in 1918 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, ORKLA has a trailing twelve months EPS of kr5.37.
PE Ratio
ORKLA has a trailing twelve months price to earnings ratio of 15.26. Meaning, the purchaser of the share is investing kr15.26 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.71%.
Volume
Today’s last reported volume for ORKLA is 146016 which is 84.7% below its average volume of 954353.
Sales Growth
ORKLA’s sales growth is 9.1% for the ongoing quarter and 17.8% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
ORKLA’s EBITDA is 34.13.
Moving Average
ORKLA’s value is higher than its 50-day moving average of kr78.81 and higher than its 200-day moving average of kr78.84.
More news about ORKLA.
4. ING GROEP N.V. (INGA.AS)
7.1% sales growth and 29.72% return on equity
ING Groep N.V., a financial institution, provides various banking products and services in the Netherlands, Belgium, Rest of Europe, North America, Latin America, Asia, and Australia. It operates in six segments: Retail Netherlands, Retail Belgium, Retail Germany, Retail Other, Wholesale Banking, and Corporate Line Banking. The company accepts various deposits, such as current and savings accounts. It also offers business lending products; consumer lending products, such as residential mortgage loans, term loans, and other consumer lending loans; and secured and unsecured lending services. in addition, the company provides debt capital market, working capital solutions, export finance, daily banking, treasury and risk, and corporate finance solutions; and specialized lending, debt and equity market solutions, payments and cash management, and trade and treasury services, as well as savings, investment, insurance, mortgage, and digital banking services; and SME loans. It serves individual customers, corporate clients, and financial institutions. ING Groep N.V. was founded in 1762 and is headquartered in Amsterdam, the Netherlands.
Earnings Per Share
As for profitability, ING GROEP N.V. has a trailing twelve months EPS of €1.62.
PE Ratio
ING GROEP N.V. has a trailing twelve months price to earnings ratio of 7.96. Meaning, the purchaser of the share is investing €7.96 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.72%.
Yearly Top and Bottom Value
ING GROEP N.V.’s stock is valued at €12.90 at 16:20 EST, below its 52-week high of €13.83 and way higher than its 52-week low of €9.59.
More news about ING GROEP N.V..
5. VISTIN PHARMA (VISTN.OL)
6.6% sales growth and 16.03% return on equity
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, VISTIN PHARMA has a trailing twelve months EPS of kr1.
PE Ratio
VISTIN PHARMA has a trailing twelve months price to earnings ratio of 23.7. Meaning, the purchaser of the share is investing kr23.7 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.03%.
Yearly Top and Bottom Value
VISTIN PHARMA’s stock is valued at kr23.70 at 16:20 EST, under its 52-week high of kr25.10 and way above its 52-week low of kr15.80.
More news about VISTIN PHARMA.
